Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction

Neurotoxicity Research

Volumn 13, Issue 1, 2008, Pages 19-30

  Kiryk, Anna ^a   Aida, Tomomi ^b   Tanaka, Kohichi ^b   Banerjee, Pradeep ^c   Wilczynski, Grzegorz M ^a   Meyza, Ksenia ^a   Knapska, Ewelina ^a   Filipkowski, Robert K ^a   Kaczmarek, Leszek ^a   Danysz, Wojciech ^d  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c FOREST RESEARCH INSTITUTE   (United States)

^d MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Behavior; GLT1 KO mice; GLT1(+ ) mice; Glutamate uptake; Histology; Immunochemistry

Indexed keywords

GLUTAMIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; NEUROTOXIN;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BODY WEIGHT; BRAIN NERVE CELL; BRAIN TISSUE; BRAIN WEIGHT; CELL LOSS; CONDITIONING; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEAR; GLIOSIS; GLUTAMATERGIC HYPERFUNCTION; HETEROZYGOSITY; HIPPOCAMPUS; HOMOZYGOSITY; IMMUNOREACTIVITY; LIFESPAN; LOCOMOTION; MOUSE; NEOCORTEX; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SENSORIMOTOR NEUROPATHY; ANIMAL; ANIMAL BEHAVIOR; BODY SIZE; DISEASE MODEL; EXPLORATORY BEHAVIOR; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; REFLEX;

MUS;

ANIMALS; BEHAVIOR, ANIMAL; BODY SIZE; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 2; EXPLORATORY BEHAVIOR; FEMALE; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MICE; MICE, MUTANT STRAINS; NEURODEGENERATIVE DISEASES; NEUROTOXINS; REFLEX;

EID: 44649181381     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033364     Document Type: Article

References (44)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945-1949.
2. Benveniste H, J Drejer, A Schusboe and NH Diemer (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
3. Carlsson M and A Carlsson (1990) Interaction between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
4. Collingridge G (1987) The role of NMDA receptors in learning and memory. Nature 330, 604-605.
5. Czuczwar SJ and BS Meldrum (1982) Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acd. Eur. J. Pharmacol. 83, 335-338.
6. Danbolt NC (2001) Glutamate uptake. Prog. Neurobiol. 65, 1-105.
7. Danysz W and CG Parsons (2002) Neuroprotective potential of ionotropic glutamate receptor antagonists - II. Neurotox. Res. 4, 119-126.
8. Danysz W and CG Parsons (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease. Preclinical evidence. Intl. J. Geriatric Psychiatry 18, S23-S32.
9. Danysz W, CG Parsons, I Bresink and G Quack (1995a) Glutamate in CNS disorders - a revived target for drug development. Drug News Perspect. 8, 261-277.
10. Danysz W, W Zajaczkowski and CG Parsons (1995b) Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 6, 455-474.
11. Eilam D, M Dank and R Maurer (2003) Voles scale locomotion to the size of the open-field by adjusting the distance between stops: A possible link to path integration. Behav. Brain Res. 141, 73-81.
12. Fradley RL, GF O'Meara, RJ Newman, A Andrieux, D Job and DS Reynolds (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav. Brain Res. 163, 257-264.
13. Gravius A, C Barberi, D Schäfer, WJ Schmidt and W Danysz (2006) The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison. Neuropharmacology 51, 1146-1155.
14. Greenamyre JT (1991) Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease - use it and lose it. Neurobiol. Aging 12, 334-336.
15. Greenamyre JT, EF Maragos, RL Albin, JB Penney and AB Young (1988) Glutamate transmission and toxicity in Alzheimer's disease. Prog. Neuro-Psych. Biol. Psychiatry 12, 421-430.
16. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67, 277-286.
17. Katagiri H, K Tanaka and T Manabe (2001) Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur. J. Neurosci. 14, 547-553.
18. Li JH, YH Wang, BB Wolfe, KE Krueger, L Corsi, G Stocca and S Vicini (1998) Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical. Eur. J. Neurosci. 10, 1704-1715.
19. Lipton SA (1992) Models of neuronal injury in AIDS-another role for the NMDA receptor. Trends Neurosci. 15, 75-79.
20. Masliah E, M Alford, R DeTeresa, M Mallory and L Hansen (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40, 759-766.
21. Masliah E, M Alford, M Mallory, E Rockenstein, D Moechars and F Van Leuven (2000) Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp. Neurol. 163, 381-387.
22. Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44, 14-23.
23. Meldrum B and J Garthwaite (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-387.
24. Mitani A and K Tanaka (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: An in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-82.
25. Nicolls D and D Attwell (1990) The release and uptake of exitatory amino acid. Trends Pharmacol. Sci. 11, 462-468.
26. Noda M, H Nakanishi and N Akaike (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-β peptide. Neuroscience 92, 1465-1474.
27. Pardo AC, V Wong, LM Benson, M Dykes, K Tanaka, JD Rothstein and NJ Maragakis (2006) Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Exp. Neurol. 201(1), 120-130. Epub 2006 Jun 6.
28. Phillips RG and JE LeDoux (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274-285.
29. Rothman SM and JW Olney (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci. 10, 299-302.
30. Rothstein JD (1995) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 3, 348-359.
31. Rothstein JD, LJ Martin and RW Kuncl (1992) Decreased gluta mate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468.
32. Rothstein JD, M Vankammen, AI Levey, LJ Martin and RW Kuncl (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
33. Schmidt WJ, M Bubser and W Hauber (1990) Excitatory amino acids and Parkinson's disease. Trends Neurosci. 13, 46.
34. Schwarcz R and C Köhler (1983) Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett. 38, 85-90.
35. Seal RP and SG Amara (1999) Excitatory amino acid transporters: A family in flux. Annu. Rev. Pharmacol. Toxicol. 39, 431-456.
36. 3 dopamine receptor-deficient mouse: Evidence for reduced anxiety. Physiol. Behav. 63, 137-141.
37. Takatsuru Y, M Iino, K Tanaka and S Ozawa (2007) Contribution of glutamate transporter GLT-1 to removal of synaptically released glutamate at climbing fiber-Purkinje cell synapses. Neurosci. Lett. 420, 85-89.
38. Tanaka K (1993) Expression cloning of a rat glutamate transporter. Neurosci. Res. 16, 149-153.
39. Tanaka K (2000) Functions of glutamate transporters in the brain. Neurosci. Res. 37, 15-19.
40. Tanaka K, K Watase, T Manabe, K Yamada, M Watanabe, K Takahashi, H Iwama, T Nishikawa, N Ichihara, T Kikuchi, S Okuyama, N Kawashima, S Hori, M Takimoto and K Wada (1997a) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699-1702.
41. Tanaka E, S Yamamoto, Y Kudo, S Mihara and H Higashi (1997b) Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro. J. Neurophysiol. 78, 891-902.
42. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349, 414-417.
43. Ueda Y, T Doi, N Tsuru, J Tokumaru and Y Mitsuyama (2002) Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice. Brain Res. Mol. Brain Res. 104, 120-126.
44. Zoia C, T Cogliati, E Tagliabue, G Cavaletti, G Sala, G Galimberti, I Rivolta, V Rossi, L Frattola and C Ferrarese (2004) Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol. Aging 25, 149-157.